Leonardo DRS, Inc. Segments Disclosure
| (Dollars in millions) | 2025 | 2024 | 2023 | ||||||||||||||
| Revenues | |||||||||||||||||
| ASC | $ | 2,355 | $ | 2,118 | $ | 1,831 | |||||||||||
| IMS | 1,307 | 1,138 | 1,021 | ||||||||||||||
| Corporate & Eliminations | (14) | (22) | (26) | ||||||||||||||
Total revenues | $ | 3,648 | $ | 3,234 | $ | 2,826 | |||||||||||
Cost of revenues | |||||||||||||||||
ASC | $ | 1,727 | $ | 1,598 | $ | 1,370 | |||||||||||
IMS | 1,066 | 922 | 834 | ||||||||||||||
Corporate & Eliminations | (14) | (22) | (26) | ||||||||||||||
Total cost of revenues | $ | 2,779 | $ | 2,498 | $ | 2,178 | |||||||||||
General and administrative | |||||||||||||||||
ASC | $ | 260 | $ | 234 | $ | 226 | |||||||||||
IMS | 101 | 81 | 79 | ||||||||||||||
Corporate & Eliminations | 7 | 7 | (3) | ||||||||||||||
Total general and administrative | $ | 368 | $ | 322 | $ | 302 | |||||||||||
| Company-funded independent research and development | |||||||||||||||||
ASC | $ | 104 | $ | 74 | $ | 66 | |||||||||||
IMS | 25 | 18 | 16 | ||||||||||||||
Corporate & Eliminations | — | — | — | ||||||||||||||
| Total company-funded independent research and development | $ | 129 | $ | 92 | $ | 82 | |||||||||||
| Amortization of acquired intangible assets | |||||||||||||||||
ASC | $ | 22 | $ | 22 | $ | 22 | |||||||||||
IMS | — | — | — | ||||||||||||||
Corporate & Eliminations | — | — | — | ||||||||||||||
| Total amortization of acquired intangible assets | $ | 22 | $ | 22 | $ | 22 | |||||||||||
Other segment items | |||||||||||||||||
ASC | $ | 2 | $ | 7 | $ | 11 | |||||||||||
IMS | — | — | — | ||||||||||||||
Corporate & Eliminations | — | — | — | ||||||||||||||
Total other segment items(1) | $ | 2 | $ | 7 | $ | 11 | |||||||||||
Operating earnings | |||||||||||||||||
ASC | $ | 240 | $ | 183 | $ | 136 | |||||||||||
IMS | 115 | 117 | 92 | ||||||||||||||
Corporate & Eliminations | (7) | (7) | 3 | ||||||||||||||
Total operating earnings | $ | 348 | $ | 293 | $ | 231 | |||||||||||
Interest expense | (8) | (21) | (36) | ||||||||||||||
Other, net | (4) | (8) | (3) | ||||||||||||||
Earnings before taxes | $ | 336 | $ | 264 | $ | 192 | |||||||||||
| (Dollars in millions) | 2025 | 2024 | 2023 | ||||||||||||||
| ASC | $ | 12 | $ | 21 | $ | 25 | |||||||||||
| IMS | 2 | 1 | 1 | ||||||||||||||
Total intersegment revenues | $ | 14 | $ | 22 | $ | 26 | |||||||||||
| (Dollars in millions) | 2025 | 2024 | 2023 | ||||||||||||||
| ASC | $ | 49 | $ | 48 | $ | 44 | |||||||||||
| IMS | 22 | 21 | 19 | ||||||||||||||
Total depreciation | $ | 71 | $ | 69 | $ | 63 | |||||||||||
| (Dollars in millions) | 2025 | 2024 | |||||||||
| ASC | $ | 2,451 | $ | 2,249 | |||||||
| IMS | 1,300 | 1,225 | |||||||||
| Corporate & Eliminations | 735 | 710 | |||||||||
Total assets | $ | 4,486 | $ | 4,184 | |||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 27, 2026 | Showing above |
| 2024 | Mar 3, 2025 | |
| 2023 | Feb 28, 2024 | |
| 2022 | Mar 28, 2023 | |
| 2021 | Mar 28, 2022 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.